Washington proposes medical cannabis testing and label changes

Washington scheduled a November 10 hearing on rules that would align medical cannabis quality testing with broader state standards and could require certificate-of-analysis access, terpene details and production dates on labels. Oklahoma manufacturers and labs can use the proposal as a compliance benchmark for patient-facing test transparency.